Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study
Résumé
Objective To estimate population-wide hepatitis B and C seroprevalence using dried blood spot samples acquired for human
immunodeficiency virus (HIV) surveillance as part of the 2010–2011 Demographic and Health Survey in Burkina Faso.
Methods We used the database acquired during the multistage, clustered, population-based survey, in which 15 377 participants completed
questionnaires and provided dried blood spot samples for HIV testing. We extracted sociodemographic and geographic data including
age, sex, ethnicity, education, wealth, marital status and region for each participant. We performed hepatitis B and C assays on 14 886 HIVnegative samples between March to October 2015, and calculated weighted percentages of hepatitis seroprevalence for each variable.
Findings We estimated seroprevalence as 9.1% (95% confidence interval, CI: 8.5–9.7) for the hepatitis B surface antigen and 3.6% (95% CI:
3.3–3.8) for hepatitis C virus antibodies, classifying Burkina Faso as highly endemic for hepatitis B and low-intermediate for hepatitis C. The
seroprevalence of hepatitis was higher in men than in women, and varied significantly for both with age, education, ethnicity and region.
Extremely high HCV-Ab seroprevalence (13.2%; 95% CI: 10.6–15.7) was identified in the Sud-Ouest region, in particular within the youngest
age group (15–20 years), indicating an ongoing epidemic.
Conclusion Our population-representative hepatitis seroprevalence estimates in Burkina Faso advocate for the inclusion of hepatitis
serological tests and risk factor questionnaire items in future surveys, the results of which are crucial for the development of appropriate
health policies and infection control programmes.
Fichier principal
Hepatitis B and C virus seroprevalence Burkina Faso a cross-sectional.pdf (825.9 Ko)
Télécharger le fichier
Origine | Fichiers éditeurs autorisés sur une archive ouverte |
---|
Loading...